AIP Stock Overview
Adcock Ingram Holdings Limited, together with its subsidiaries, engages in the manufacture, marketing, and distribution of healthcare products in South Africa, the United States, Canada, the United Kingdom, rest of Europe, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 1/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
Adcock Ingram Holdings Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | R52.67 |
| 52 Week High | R61.48 |
| 52 Week Low | R49.58 |
| Beta | 0.31 |
| 1 Month Change | -4.11% |
| 3 Month Change | -8.02% |
| 1 Year Change | 2.67% |
| 3 Year Change | 19.43% |
| 5 Year Change | -18.34% |
| Change since IPO | 54.68% |
Recent News & Updates
Shareholder Returns
| AIP | ZA Pharmaceuticals | ZA Market | |
|---|---|---|---|
| 7D | -5.4% | 1.7% | 1.9% |
| 1Y | 2.7% | 17.0% | -1.8% |
Return vs Industry: AIP underperformed the ZA Pharmaceuticals industry which returned 16.3% over the past year.
Return vs Market: AIP exceeded the ZA Market which returned -1.3% over the past year.
Price Volatility
| AIP volatility | |
|---|---|
| AIP Average Weekly Movement | 3.7% |
| Pharmaceuticals Industry Average Movement | 3.9% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in ZA Market | 11.6% |
| 10% least volatile stocks in ZA Market | 2.8% |
Stable Share Price: AIP has not had significant price volatility in the past 3 months.
Volatility Over Time: AIP's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1890 | n/a | Andy Hall | www.adcock.co.za |
Adcock Ingram Holdings Limited, together with its subsidiaries, engages in the manufacture, marketing, and distribution of healthcare products in South Africa, the United States, Canada, the United Kingdom, rest of Europe, and internationally. It operates through four divisions: Consumer, Over the Counter (OTC), Prescription, and Hospital Products and Services. The company is involved in the sale of various healthcare, personal care, and homecare products through FMCG retailers and corporate pharmacies; OTC medicinal products through corporate and independent pharmacies; branded and generic prescription products, and specialized instrumentation and surgical products; and hospital products in oral solid dosage formulations, syrups, intravenous, and injectable dosage forms.
Adcock Ingram Holdings Limited Fundamentals Summary
| AIP fundamental statistics | |
|---|---|
| Market cap | R7.95b |
| Earnings (TTM) | R874.23m |
| Revenue (TTM) | R9.20b |
9.1x
P/E Ratio0.9x
P/S RatioIs AIP overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| AIP income statement (TTM) | |
|---|---|
| Revenue | R9.20b |
| Cost of Revenue | R6.07b |
| Gross Profit | R3.12b |
| Other Expenses | R2.25b |
| Earnings | R874.23m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 5.79 |
| Gross Margin | 33.96% |
| Net Profit Margin | 9.51% |
| Debt/Equity Ratio | 3.3% |
How did AIP perform over the long term?
See historical performance and comparison